Quick navigation menu :

You are here :

Home

Menu outils :

Primary navigation :

International presence

Quick links

Publications

Diary

Financial calendar

Headline

New vaccine manufacturing facility

Dengue vaccine

Find out more about our commitment

First Quarter 2009 Results

April 29: Audio webcast of the conference call

To find out more about this event

April 29: Interview with Chris Viehbacher

Access the video

Combined General Meeting 2009

Access all the information

Latest publications

RSS Press releases

All press releases

May 12, 2009

Sanofi-aventis builds a New Vaccine Manufacturing Facility in France with an investment of 350 million euros

May 6, 2009

U.S. FDA Licenses Sanofi Pasteur’s New Influenza Vaccine Manufacturing Facility

May 6, 2009

Sanofi-aventis has successfully completed the placement of a 4-year and a 7-year Euro notes issue for an aggregate principal amount of EUR 3 billion

May 5, 2009

Sanofi-aventis converts its Vitry-sur-Seine Industrial Facility to Biotechnologies

Euronext Paris (SAN)

Quote: €43.88. Level change: -0.28%
Last update: May 12, 2009 05.39 PM (CET)

NYSE (SNY)

Quote: $29.86. Level change: -0.02%
Last update: May 12, 2009 04.10 PM (EST)

Pandemic preparedness plan

Sanofi Pasteur website

Working for sustainability

Sustainability website

In partnership with sanofi-aventis

For more information